J. Matthew Rhett

1.8k total citations
30 papers, 1.5k citations indexed

About

J. Matthew Rhett is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Matthew Rhett has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Matthew Rhett's work include Connexins and lens biology (17 papers), Nicotinic Acetylcholine Receptors Study (8 papers) and Heat shock proteins research (6 papers). J. Matthew Rhett is often cited by papers focused on Connexins and lens biology (17 papers), Nicotinic Acetylcholine Receptors Study (8 papers) and Heat shock proteins research (6 papers). J. Matthew Rhett collaborates with scholars based in United States. J. Matthew Rhett's co-authors include Robert G. Gourdie, Jane Jourdan, Joseph A. Palatinus, Gautam S. Ghatnekar, Michael J. Yost, Michael P. O’Quinn, John P. O’Bryan, Imran Khan, Thomas P. Smith and Robert T. Dillon and has published in prestigious journals such as Circulation, Oncogene and The FASEB Journal.

In The Last Decade

J. Matthew Rhett

29 papers receiving 1.4k citations

Peers

J. Matthew Rhett
Mahasweta Girgenrath United States
Andrew H Williams United States
Matthew Gemberling United States
M. Kloc United States
Mahasweta Girgenrath United States
J. Matthew Rhett
Citations per year, relative to J. Matthew Rhett J. Matthew Rhett (= 1×) peers Mahasweta Girgenrath

Countries citing papers authored by J. Matthew Rhett

Since Specialization
Citations

This map shows the geographic impact of J. Matthew Rhett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Matthew Rhett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Matthew Rhett more than expected).

Fields of papers citing papers by J. Matthew Rhett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Matthew Rhett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Matthew Rhett. The network helps show where J. Matthew Rhett may publish in the future.

Co-authorship network of co-authors of J. Matthew Rhett

This figure shows the co-authorship network connecting the top 25 collaborators of J. Matthew Rhett. A scholar is included among the top collaborators of J. Matthew Rhett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Matthew Rhett. J. Matthew Rhett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Imran, Akiko Koide, Mariyam Zuberi, et al.. (2022). Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants. Cell Reports. 38(6). 110322–110322. 14 indexed citations
2.
Scalise, Carly Bess, J. Matthew Rhett, Scott T. Eblen, et al.. (2021). Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene. 40(20). 3635–3636. 1 indexed citations
3.
Rhett, J. Matthew, Imran Khan, & John P. O’Bryan. (2020). Biology, pathology, and therapeutic targeting of RAS. Advances in cancer research. 148. 69–146. 22 indexed citations
4.
Khan, Imran, J. Matthew Rhett, & John P. O’Bryan. (2019). Therapeutic targeting of RAS: New hope for drugging the “undruggable”. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(2). 118570–118570. 79 indexed citations
5.
Scalise, Carly Bess, J. Matthew Rhett, Scott T. Eblen, et al.. (2019). HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene. 39(5). 1112–1124. 29 indexed citations
6.
Nadig, Satish N., Heather A. Bainbridge, J. Matthew Rhett, et al.. (2018). Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology. Journal of Visualized Experiments. 1 indexed citations
7.
Grek, Christina L., et al.. (2016). Connexin 43, breast cancer tumor suppressor: Missed connections?. Cancer Letters. 374(1). 117–126. 43 indexed citations
8.
Calder, Bennett W., J. Matthew Rhett, Heather A. Bainbridge, et al.. (2015). Inhibition of Connexin 43 Hemichannel-Mediated ATP Release Attenuates Early Inflammation During the Foreign Body Response. Tissue Engineering Part A. 21(11-12). 1752–1762. 56 indexed citations
10.
Grek, Christina L., J. Matthew Rhett, & Gautam S. Ghatnekar. (2014). Cardiac to cancer: Connecting connexins to clinical opportunity. FEBS Letters. 588(8). 1349–1364. 38 indexed citations
11.
Rhett, J. Matthew, Stephen A. Fann, & Michael J. Yost. (2013). Purinergic Signaling in Early Inflammatory Events of the Foreign Body Response: Modulating Extracellular ATP as an Enabling Technology for Engineered Implants and Tissues. Tissue Engineering Part B Reviews. 20(5). 392–402. 21 indexed citations
12.
Rhett, J. Matthew, Rengasayee Veeraraghavan, Steven Poelzing, & Robert G. Gourdie. (2013). The perinexus: Sign-post on the path to a new model of cardiac conduction?. Trends in Cardiovascular Medicine. 23(6). 222–228. 64 indexed citations
13.
Rhett, J. Matthew, Emily L. Ongstad, Jane Jourdan, & Robert G. Gourdie. (2012). Cx43 Associates with Nav1.5 in the Cardiomyocyte Perinexus. The Journal of Membrane Biology. 245(7). 411–422. 106 indexed citations
14.
Rhett, J. Matthew, Joseph A. Palatinus, Jane Jourdan, & Robert G. Gourdie. (2011). Abstract 9561: Connexin43 Interacts with Voltage-Gated Sodium Channel 1.5 in the Perinexus. Circulation. 124(suppl_21). 5 indexed citations
15.
Palatinus, Joseph A., J. Matthew Rhett, & Robert G. Gourdie. (2011). The connexin43 carboxyl terminus and cardiac gap junction organization. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1818(8). 1831–1843. 70 indexed citations
16.
Rhett, J. Matthew & Robert G. Gourdie. (2011). The perinexus: A new feature of Cx43 gap junction organization. Heart Rhythm. 9(4). 619–623. 82 indexed citations
17.
Palatinus, Joseph A., J. Matthew Rhett, & Robert G. Gourdie. (2011). Enhanced PKCε mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury. Channels. 5(3). 236–240. 36 indexed citations
18.
Palatinus, Joseph A., J. Matthew Rhett, & Robert G. Gourdie. (2009). Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium. Journal of Molecular and Cellular Cardiology. 48(3). 550–557. 32 indexed citations
19.
Virella, Gabriel, Suzanne R. Thorpe, Nathan L. Alderson, et al.. (2004). Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies. Journal of Lipid Research. 45(10). 1859–1867. 49 indexed citations
20.
Dillon, Robert T., Amy R. Wethington, J. Matthew Rhett, & Thomas P. Smith. (2002). Populations of the European freshwater pulmonate Physa acuta are not reproductively isolated from American Physa heterostropha or Physa integra. Invertebrate Biology. 121(3). 226–234. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026